Back to Search
Start Over
Inferred Gene Expression By Cell-Free DNA Profiling Allows Noninvasive Lymphoma Classification
- Source :
- Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p245-245, 1p
- Publication Year :
- 2023
-
Abstract
- Background:Current diagnostic criteria for mature B-cell tumors require a combination of histopathological, immunophenotypic, cytogenetic, and genetic evaluations on tissue biopsy specimens (Campo, Blood2022; Alaggio, Leuk2022). Despite this battery of techniques, substantial heterogeneity remains in specific subgroups that can be further resolved using additional molecular diagnostic methods, including gene expression profiling (GEP). For example, among aggressive B-cell tumors, a subset recognized as high-grade B-cell lymphomas can be identified as harboring MYC+BCL2 lesions by FISH (HGBCL-DH-BCL2). However, a significant remaining high-risk subset also have a characteristic tumor gene expression “double-hit signature” or “dark zone signature” (DZsig) (Ennishi, JCO2018; Alduaij, Blood2023).
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 142
- Issue :
- 1, Number 1 Supplement 1
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs64699416
- Full Text :
- https://doi.org/10.1182/blood-2023-186853